ISTH/LinkedIn
Aug 14, 2026, 06:26
Delivering Gene Therapy in Hemophilia – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared on LinkedIn:
“Delivering gene therapy in hemophilia isn’t just a clinical decision, it’s an operational one. From referral pathways to long-term monitoring, successful implementation requires coordination across teams, systems, and care models.
Our new resource builder helps you not only navigate referral, preparation, and administration workflows, but grants you access to tools tailored to your region and practice setting.
Support your team in managing the complexities of gene therapy by building a personalized set of implementation resources and taking the next step toward integrating gene therapy into practice!”
Stay updated with Hemostasis Today.
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL
-
Nov 12, 2026, 22:44Mary Cushman: New Position at the Vermont Center for Cardiovascular and Brain Health
-
Nov 12, 2026, 22:43Lama Alstanbuli: Discussing and Optimizing Stroke Pathways Across Healthcare Systems
-
Nov 12, 2026, 22:35Carmen’s Recovery From Spontaneous Coronary Artery Dissection – American Heart Association
-
Nov 12, 2026, 22:34What’s Next in Comprehensive Care for Hemophilia and Other Bleeding Disorders? – WFH